Claude Zehnder

Barclays Bank Plc provides commercial banking services. It offers personal, premier, business and corporate banking products and services to its customers. The banks services include current accounts, savings, investments, mortgages, loans, insurance, credit cards and online banking services. The company was founded on October 4, 1971 and is headquartered in London, the United Kingdom.

Zürcher Kantonalbank engages in the provision of universal banking services. It offers its services through the following divisions: Private Banking, International Banking and Asset Management. The Private Banking division offers private advisory, asset management, fiduciary and other services. The International Banking division provides international payments and trade finance services. The Asset Management division includes segregated, balanced and overlay mandates. It also offers strategy advice and portfolio analysis services. The company was founded on February 15, 1870 and is headquartered in Zürich, Switzerland.

Credit Suisse AG (Private Banking) (CSPB) is the Zurich-based private banking division of Credit Suisse AG, itself a subsidiary of Credit Suisse Group AG (VX: CSGN) in Switzerland. Established in 1856, CSPB provides comprehensive advice and a range of investment products and services to private, corporate and institutional clients. The firm is a leading provider of innovative alternative investment products. Their wealth management solutions include tax planning, pension planning, life insurance solutions, wealth and inheritance advice, trusts and foundations.

UBS Securities Asia Ltd. (UBS Asia) is a brokerage firm headquartered in Hong Kong. The firm is a subsidiary of UBS AG, which is owned by UBS Group AG (SWX: UBSG) in Switzerland. UBS Asia provides corporate and institutional clients which include intermediary and alternative asset managers with financial advisory services, access to the world's capital markets and securities products and research in the field of equity, fixed-income, rates, foreign exchange, energy and metals.

Pictet Asset Management SA (Pictet AM) is the asset management subsidiary of Pictet Asset Management Holding SA, ultimately held by Banque Pictet & Cie in Switzerland. Established in 1967, the firm is headquartered in Geneva with investment management centers in Zurich, London, Singapore and Tokyo. They also have marketing client service centers in major cities worldwide. Pictet AM manages a range of equity, fixed income, alternative and multi asset products. They provide specialist investment services through segregated accounts and investment funds to some of the world’s largest pension funds, financial institutions, sovereign wealth funds, intermediaries and their clients. Pictet AM is a responsible investor and signatory to the UN Principles for Responsible Investment.

ODDO BHF AG (Broker) (ODDO BHF-Broker) is the broker/dealer division of ODDO BHF AG, which is owned by Oddo BHF SCA in German. The firm was founded in 1854 and is headquartered in Frankfurt. ODDO BHF-Broker offers a wide range of high value-added broking services for issuers, holding companies and/or family offices.

Zürcher Kantonalbank (Investment Management) (ZKB-IM) is the investment management division of Zürcher Kantonalbank, a Swiss full-service bank headquartered in Zurich. Founded in 1870, ZKB-IM performs the bank's investment activities, including financial advisory services, research, trading, and asset management. The asset management division provides investment solutions for institutional, corporate and private clients, managing discretionary mandates and the ZKB range of mutual funds. Their mission includes fostering economic growth in the Canton of Zurich.

Credit Suisse Securities Europe Ltd. (Switzerland) is the Swiss broker/dealer division of Credit Suisse Securities Europe Ltd. in Great Britain. They are ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Headquartered in Zurich, the firm offers equities and fixed income sales and trading services, and provides access to a range of debt and equity securities, derivative products and financing opportunities across the capital spectrum for corporate, sovereign and institutional clients.

Founded in 2003, Stifel Schweiz AG is a full-service investment bank. Part of Stifel Financial Corp., the Swiss company is headquartered in Zurich, Switzerland, with offices in multiple locations. The company provides a range of investment banking services.

Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria.

Swiss Bankers Association operates bankers association. The company was founded by Robert U. Vogler in 1912 and is headquartered in Basel, China.

Kizoo Technology Capital GmbH (KIZOO) is the venture capital arm of Atevia AG, itself a subsidiary of Cinetic Gesellschaft zur Entwicklung & Vertrieb von Medien. The firm was founded by Michael Greve, Matthias Hornberger, and Frank Schüler in 2006. It is headquartered in Karlsruhe, Germany.

Commerzbank AG (Broker) (Commerzbank-Broker) is the brokerage division of Commerzbank AG (ETR: CBK) in Germany. In 2009, following Commerzbank's acquisition of Dresdner Kleinwort the group created a Corporates & Markets platform which integrated the business of Dresdner Kleinwort GmbH-Investment Management. Headquartered in Frankfurt, Commerzbank-Broker provides trade solutions to multinational corporations, institutional investors, public entities, SMEs and private clients. They also offer risk management and structured financing solutions.

Deutsche Bank (Suisse) SA (Broker) (Deutsche Bank Switzerland) is the securities brokerage division of Switzerland-based Deutsche Bank (Suisse) SA, which is owned by Deutsche Bank AG (ETR: DBK) in Germany. The firm is headquartered in Zurich and was founded in 1980. Deutsche Bank Switzerland is responsible for macro and microanalysis within Deutsche Bank Group and acts as consultant for the bank, its clients and stakeholders. They analyze relevant trends for the bank in financial markets, the economy and society and highlight risks and opportunities. The firm delivers high-quality, independent analysis and actively promotes public debate on economic, fiscal, labor market and social policy issues.

Bank J. Safra Sarasin AG (Broker) (Bank J. Safra Sarasin-Broker) is the brokerage division of Bank J. Safra Sarasin AG, a private bank headquartered in Basel, Switzerland. The firm was founded in 1841 and is a subsidiary of J. Safra Sarasin Holding AG, ultimately held by JS International Holdings Ltd. in the Bahamas. The firm is headquartered in Basel and. Bank J. Safra Sarasin-Broker offers brokerage services in securities, derivatives, currencies and precious metals for institutional clients.

Octavian AG is a Swiss company that specializes in equity market expertise and research for high alpha investors. The private company is based in Zurich, Switzerland. The company also facilitates high-quality investor events and are a trusted corporate finance advisor. Octavian was founded in 2017 by Dan Potashnick, Martin Schuler, René Saner, Serge Monnerat, Stephen Leventhal, Laura Pfeifer-Rossi, Alessandro Foletti.

Aargauische Kantonalbank (Invt Mgmt) (AKB-IM) is the asset management division of state-owned Aargauische Kantonalbank, a cantonal bank headquartered in Aarau, Switzerland. Founded in 1913, AKB-IM provides investment advisory and management services to private and corporate clients.

Luzerner Kantonalbank AG (Private Banking) (LUKB-PB) is the private banking division of State of Lucerne-owned Luzerner Kantonalbank AG in Switzerland. Founded in 1850 as KantonaleSpar-und Leihkasse, the firm changed their name to Luzerner Kantonalbank in 1892. In 2006, they acquired private banking team Adler & Co. PrivatbankAG and in 2010 Adler & Co. PrivatbankAG merged into Luzerner Kantonalbank AG. LUKB-PB is based in Lucerne with an additional office in Zurich. They providesa full range of private banking services, including wealth management advice, for small and medium-sized enterprises in Canton Lucerne and the rest of German-speaking Switzerland.

1741 Fund Solutions AG is an independent, management-owned fund management firm headquartered in St. Gallen, Swizterland. The firm was founded in 1998 and formerly known as Wegelin Fondsleitung AG and as Vescore Fondsleitung AG. 1741 Fund Solutions acts as Swiss representative for foreign investment funds distributed in Switzerland.

Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland.

Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA.

BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland.

LIfT BioSciences Ltd. is a pre-clinical stage biotech company based in Brighton, UK. LIfT BioSciences is developing a first-in-class alpha neutrophil cell therapy called N-Lift, which is produced from a patented process using exceptional stem cells, a proprietary enhancement media, and genetic engineering. The therapy is designed to destroy solid tumors both directly and indirectly by turning the tumor microenvironment against the tumor and recruiting the rest of the immune system to destroy it. The British company is working with a range of pharmaceutical license partners across oncology, immunology, neurology, and AMR to develop a portfolio of immune-modulatory alpha neutrophils for treating a range of therapeutic indications, including solid tumors. The company's goal is to deliver complete remission in high unmet need solid tumors before the decade is out. The company was founded in 2014 by Alexander William Blyth, who was inspired to create the company after his mother passed away from pancreatic cancer.

PG Impact Investments AG operates as a investment firm. It serves international clientele of professional investors who seek investment solutions that offer financial returns, while also helping to address pressing social or environmental challenges. The company was founded by Urs Wietlisbach and Urs Daniel Baumann in 2015 and is headquartered in Baar, Switzerland.

Schweizerische Nationalbank (Investment Portfolio) (SNB-IP) is the investment portfolio division of Schweizerische Nationalbank (SW: SNBN) in Switzerland. The firm was founded in 1907 and is headquartered in Zurich. SNB-IP manages the assets of the Swiss National Bank, consisting of foreign currency, gold and Swiss francs, as determined by the established monetary order and the requirements of monetary policy.

3horizons AG is a Swiss company that leases real estate. The private company is based in Sursee, Switzerland.

Mckinsey & Co. (Switzerland) provides business management consulting services. The private company is based in Geneva, Switzerland.

Swisscard AECS GmbH operates as a credit card company. The firm’s credit card brands include American Express, Mastercard, and Visa. It also offers bonus program, insurance, mobile payment, and online services. The company was founded in 1998 and is headquartered in Horgen, Switzerland.

APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria.